QR-koodi

Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease

Background Patients with essential thrombocythemia (ET) and coronary artery disease (CAD) have increased risk of thromboembolic complications. In addition, a reduced antiplatelet effect of aspirin has been demonstrated in both patient groups. As ET is a platelet disorder, platelets may be more impor...

Täydet tiedot

Tallennettuna:
Päätekijät: Oliver Buchhave Pedersen, Anne-Mette Hvas, Hans Beier Ommen, Steen Dalby Kristensen, Erik Lerkevang Grove
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Georg Thieme Verlag KG 2021-07-01
Sarja:TH Open
Aiheet:
aspirin
essential thrombocythemia
platelet aggregation
thromboxane b2
platelet activation
platelet function test
coronary artery disease
Linkit:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731309
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia